Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Could These 3 Potential Blockbusters Transform Biogen?
Could These 3 Potential Blockbusters Transform Biogen?
Could These 3 Potential Blockbusters Transform Biogen?
Submitted by
admin
on July 26, 2021 - 9:04am
Source:
Motley Fool
News Tags:
Biogen
zuranolone
depression
TMS-007
stroke
Aduhelm
Alzheimer's disease
Headline:
Could These 3 Potential Blockbusters Transform Biogen?
snippet:
Newly commercialized Aduhelm and two pipeline candidates could be game changers.
The controversial Aduhelm should offer us clues about Biogen’s future over the coming year.
Biogen shares are only about $100 away from their record high.
Do Not Allow Advertisers to Use My Personal information